Needle and syringe programmes: consultation on the evidence
NICE was asked by the Department of Health (DH) to develop public health intervention guidance to encourage the optimal provision of needle exchange schemes amongst injecting drug misusers. The scope is available from the NICE website.
All registered stakeholders are now invited to comment on the evidence that has been assembled to inform the development of this guidance. This evidence will be used by the Public Health Interventions Advisory Committee (PHIAC) to develop draft recommendations. The evidence comprises a review of effectiveness and cost effectiveness, a review of qualitative evidence and an economic analysis.
Key areas for comment:
The aim of this consultation is to enable stakeholders to consider the evidence gathered and to provide the opportunity to comment, in particular on:
- major gaps in the evidence gathered, including papers in the published literature that we have not been able to identify
- queries around the interpretation of the evidence, both of single studies and the reviewed material as a whole
- the applicability of the evidence and its usefulness for the development of guidance
- issues relating to equality
- issues relating to cost-effectiveness
Registered stakeholders are also invited to submit relevant additional evidence for consideration. In order for NICE to be able to produce guidance in a timely fashion, materials should be:
- relevant to the questions set out in the scope document
- currently not included in the evidence reviews
- provided as a PDF or electronic link to an accessible version of the complete document
(If it is not possible to submit additional evidence electronically, please contact the Project Co-ordinator to make alternative arrangements)
Any material submitted by stakeholders during this consultation will be assessed for its relevance using NICE's standard methods, as set out in the 'Methods for development of NICE public health guidance' available on the NICE website. Relevant material will be included in a supplementary report to the PDG
The consultation on this evidence will run from 20th June to 18th July 2008.
Please provide all responses to this consultation on the of evidence electronically using the Stakeholder Comments Form (ensuring all relevant fields are completed, including your organisation's name) and forward this, along with any additional evidence you are submitting, by 5pm on Friday 18th July 2008 at the very latest to the following email address: email@example.com
The review of effectiveness and cost effectiveness was carried out by the Centre for Public Health, Liverpool John Moores University.
The review of the qualitative evidence was carried out by at Leeds Metropolitan University.
The economic modelling was conducted by the Department of Public Health and Policy at London School of Hygiene and Tropical Medicine, Bristol University and Imperial College, University of London.
Please note, the evidence presented here does not constitute the Institute's guidance on this topic. NICE will issue draft guidance on Needle and syringe programmes in September 2008.
This page was last updated: 30 March 2010